Vanguard FTSE Developed Markets ETF
VEADividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| June 23, 2026 | $0.38 | 2026-06-18 | 2026-06-18 |
| March 24, 2026 | $0.11 | 2026-03-20 | 2026-03-20 |
| December 23, 2025 | $1.04 | 2025-12-19 | 2025-12-19 |
| September 23, 2025 | $0.29 | 2025-09-19 | 2025-09-19 |
| June 24, 2025 | $0.44 | 2025-06-20 | 2025-06-20 |
Dividends Summary
- Consistent Payer: Vanguard FTSE Developed Markets ETF has rewarded shareholders with 66 dividend payments over the past 19 years.
- Total Returned Value: Investors who held VEA shares during this period received a total of $23.70 per share in dividend income.
- Latest Payout: The most recent dividend of $0.38/share was paid 25 days ago, on June 23, 2026.
- Yield & Schedule: VEA currently pays dividends quarterly with an annual yield of 2.60%.
- Dividend Growth: Since 2007, the dividend payout has decreased by 64.2%, from $1.05 to $0.38.
Company News
The article argues that while S&P 500 ETFs remain a solid investment, the Vanguard FTSE Developed Markets ETF (VEA) may be a smarter choice currently. International developed markets have outperformed U.S. stocks over the past 12-18 months, with VEA up 15% year-to-date versus VOO's 10%. Wall Street experts, including Vanguard, Charles Schwab, and...
International stocks surged over 30% in 2025, with both the Vanguard FTSE Developed Markets ETF (VEA) and iShares Core MSCI Total International Stock ETF (IXUS) delivering strong returns. VEA offers lower costs and focuses on developed markets, while IXUS provides broader diversification including emerging markets. Both remain attractively valued...
South Korea's stock market has surged 55% year-to-date, driven primarily by semiconductor giants Samsung Electronics and SK Hynix capitalizing on AI-driven demand for memory chips. However, ETF investors should be aware that Korea ETFs like EWY are heavily concentrated bets on semiconductors rather than diversified country exposure. To mitigate c...
Kopp Family Office reduced its Viridian Therapeutics stake by 117,878 shares ($3.5M) in Q1 2026, cutting the position from 3.4% to 0.7% of AUM. The move appears prescient as Viridian shares have fallen 50% since mid-March following disappointing Phase 3 data for elegrobart and stronger competing results from Amgen's Tepezza variant, raising quest...
Forefront Analytics, LLC increased its holding in iShares ESG Aware MSCI EM ETF (ESGE) by 165,743 shares, bringing its total stake to 363,728 shares valued at $16.07 million. The position now represents 14.18% of the firm's 13F reportable assets. ESGE shares have appreciated 40% over the past year, outperforming the S&P 500 by 29 percentage points.
